In the BioHarmony Drug Report Database

"Preview" Icon

Tecovirimat

Tpoxx (tecovirimat) is a small molecule pharmaceutical. Tecovirimat was first approved as Tpoxx on 2018-07-13. It is used to treat smallpox in the USA. Tpoxx’s patents are valid until 2031-03-23 (FDA).

 

Trade Name

 

Tpoxx
 

Common Name

 

tecovirimat
 

ChEMBL ID

 

CHEMBL1257073
 

Indication

 

smallpox
 

Drug Class

 

Antivirals: antiviral, disrupts viral maturation

Image (chem structure or protein)

Tecovirimat structure rendering